Marietta Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,935
Closed -$1.61M 115
2019
Q3
$1.61M Sell
6,935
-61
-0.9% -$14.2K 0.59% 67
2019
Q2
$1.64M Buy
6,996
+626
+10% +$145K 0.64% 65
2019
Q1
$1.51M Buy
6,370
+812
+15% +$256K 0.62% 66
2018
Q4
$1.67M Sell
5,558
-94
-2% -$30K 0.8% 57
2018
Q3
$2M Buy
5,652
+42
+0.7% +$14.5K 0.88% 53
2018
Q2
$1.63M Buy
5,610
+461
+9% +$130K 0.79% 58
2018
Q1
$1.41M Buy
5,149
+883
+21% +$274K 0.74% 58
2017
Q4
$1.36M Buy
4,266
+282
+7% +$90.5K 0.74% 60
2017
Q3
$1.25M Buy
+3,984
New +$1.18M 0.7% 59

Other funds holding BIIB

Marietta Wealth Management's BIIB Position: Q4 2019 in Review

Marietta Wealth Management sold out of Biogen (BIIB) in Q4 2019, closing a stake of 6,935 shares — an estimated $1.61M sold.

Marietta Wealth Management first reported a position in BIIB in Q3 2017 and held it in 9 quarters. The position peaked at $2M in Q3 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Marietta Wealth Management reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Marietta Wealth Management sold 6,935 Biogen shares in Q4 2019, an estimated $1.61M.
  • Marietta Wealth Management first reported a position in Biogen in Q3 2017 and held it in 9 quarters.
  • Marietta Wealth Management's Biogen position peaked at $2M in Q3 2018.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Marietta Wealth Management's 13F filing for Q4 2019, filed 7 Feb 2020.